Scientific Informatics & Analytical Platforms - software & AI news

Daily news on software, AI, and companies shaping scientific informatics & analytical platforms.

Showing 21 results
Open notebook with notes and a pen on a conference table

May 26, 2026

C Platform accelerates push into pharma and biotech AX market

C Platform is intensifying its efforts in the pharmaceutical and biotech sectors by hosting a seminar focused on AI-driven research and development strategies.During the seminar, C Platform collaborated with industry leaders HPE, W&B (Weights & Biases Korea), and NovaDX to explore the integration of AI infrastructure and MLOps platforms tailored to the unique requirements of R&D environments. Emphasizing the importance of these tools, C Platform highlighted how they can enhance return on investm
Minimalist illustration of an enzyme molecule and a laboratory flask on a dark background.

May 21, 2026

Manchester Imperagen raises €5.8 million Seed to scale AI and quantum-powered enzyme engineering

Imperagen, a biotech firm based in Manchester, has secured €5.8 million in Seed funding to enhance its AI and quantum-powered enzyme engineering capabilities. This investment aims to boost research and development, expand laboratory facilities, and strengthen market entry strategies over the next 18 months.The funding round was spearheaded by PXN Ventures, with contributions from existing investors like IQ Capital and Northern Gritstone, bringing the total capital raised by Imperagen to €9.8 mil
A test tube with an enzyme sample in a laboratory setting.

May 21, 2026

Imperagen Raises $5 Million to Reinvent Enzyme Engineering With AI

Imperagen has successfully secured $5 million in funding to enhance its AI-driven enzyme engineering platform, targeting significant advancements in enzyme design for various industries including pharmaceuticals, agriculture, and industrial biotechnology.The company aims to revolutionize the traditionally slow and costly process of enzyme engineering by integrating artificial intelligence with physics-based simulations and automated lab testing. Its "closed-loop" system leverages machine learnin
A test sample and microscope in a dimly lit lab setting

May 18, 2026

Revvity stock (US76155R1086): collaboration momentum and diagnostics focus after recent share move

Revvity's recent stock performance has been invigorated by a collaboration with Eli Lilly aimed at enhancing predictive modeling capabilities through the Revvity Signals platform. This partnership aligns with the company's strategic focus on diagnostics and life sciences, drawing attention from investors and analysts alike.Following a nearly 5% rise in share price to around $109, Revvity has captured investor interest, particularly in light of its recent quarterly performance and strategic insig
A petri dish with a cell sample in a lab setting

May 14, 2026

CellSAM: AI Biotech Breakthrough For Cell Imaging

CellSAM represents a significant advancement in AI-driven cell imaging, promising to streamline laboratory workflows and enhance research efficiency.The CellSAM model, developed from the Vision Transformer architecture, integrates an object detection module called CellFinder, which automates the generation of bounding boxes for individual cells. This modular approach allows for independent updates to its components, facilitating adaptability in various research environments. The training process
Flat illustration of HPLC and mass spectrometry systems in a lab setting

May 14, 2026

Waters Corporation stock (US9418481035): Analytical instruments leader for US life sciences

Waters Corporation is a prominent player in the analytical instruments sector, particularly for the US life sciences market, providing essential tools for biotech and pharmaceutical research.Waters Corporation specializes in developing and manufacturing analytical instruments, notably high-performance liquid chromatography (HPLC) and mass spectrometry systems. These technologies are crucial for drug discovery and quality assurance, catering to the growing demands of the life sciences industry in
A minimalist representation of a cell with an AI control panel overlay in a dark color scheme.

May 12, 2026

Tolemy Bio raises €1.4m to build AI control panel for cell biology

Tolemy Bio has successfully raised €1.4 million to enhance its AI-driven platform aimed at revolutionizing cell biology experimentation.The funding round, led by Norrsken Evolve and supported by several venture firms, will enable Tolemy Bio to expand its data generation and machine learning capabilities, further develop its core product, Orbit, and facilitate early deployments with academic and industry collaborators. This initiative addresses a significant challenge in biopharma: the need for r
Minimalist illustration of a protein structure

May 7, 2026

Google Cloud’s Shweta Maniar on moving life-sciences AI from research to reality

Google Cloud is actively transitioning AI applications in life sciences from research phases to practical, everyday use, according to Shweta Maniar, the company’s director of strategic industries for healthcare and life sciences.Central to this initiative is AlphaFold, a tool developed by DeepMind that is now accessible for noncommercial research. This has catalyzed the emergence of various structure-prediction systems, enhancing researchers' ability to interpret complex biological data. Google’
Automated diagnostic device in a clinical lab setting

Apr 26, 2026

Is Bruker (BRKR) Quietly Recasting Its Diagnostic Edge With New Automated, AI-Driven Platforms?

Bruker is making significant strides in the diagnostics sector with the launch of its MyGenius PRO molecular diagnostics platform and enhancements to its microbiology solutions, reflecting a focus on automation and AI integration.In April 2026, Bruker introduced the MyGenius PRO platform in Europe, along with upgrades to its MALDI and IR Biotyper solutions, and new NMR and DNP products. These innovations are aimed at bolstering sensitivity and automation in research and applied workflows, emphas